Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIME IS MUSCLE: early IVIg added to prednisone in newly diagnosed myositis
NL-OMON26160Recruiting
- Sponsor
- Princess Beatrix Spierfonds
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in Autoimmune Myopathies, dermatomyositis (DM), Overlap Myositis (OM) and 2 more comparing IVIg + prednisone with Placebo + prednisone (2 arms). Primary endpoint: Change in Total Improvement Score. Started Sep 2021; status: recruiting.
02
Drugs
immune globulinprednisone
03
Conditions
Autoimmune Myopathiesdermatomyositis (DM)Overlap Myositis (OM)antisynthetase syndrome (ASSD)immune-mediated necrotizing myopathy (IMNM)
Beyond the preview
Go deeper on NL-OMON26160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26160.